Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Palbociclib | Palbociclib is an orally available cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity. Palbociclib selectively inhibits cyclin-dependent kinase 4 (CDK4) and 6 (CDK6), thereby inhibiting retinoblastoma (Rb) protein phosphorylation early in the G1 phase leading to cell cycle arrest. Group: Pharmaceutical. CAS No. 571190-30-2. Pack Sizes: 5 g. Product ID: BBF-05853. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Palbociclib HCl | Palbociclib, also known as PD0332991, is an orally available pyridopyrimidine-derived cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity. PD-0332991 selectively inhibits cyclin-dependent kinases (particularly Cdk4/cyclin D1 kinase), which may inhibit retinoblastoma (Rb) protein phosphorylation; inhibition of Rb phosphorylation prevents Rb-positive tumor cells from entering the S phase of the cell cycle (arrest in the G1 phase), resulting in suppression of DNA replication and decreased tumor cell proliferation. PD 0332991 is a highly specific inhibitor of cyclin-dependent kinase 4 (Cdk4) (IC50=0.011 μmol/L) and Cdk6 (IC50=0.016 μmol/L), having no activity against a panel of 36 additional protein kinases. Group: Pharmaceutical. CAS No. 827022-32-2. Pack Sizes: 1 g. Product ID: B2693-462758. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurities | Palbociclib Impurities are critical in the biomedical industry for quality control and drug formulation research. They help in the synthesis, analysis, and development of Palbociclib, a prominent CDK4/6 inhibitor used in treating hormone receptor-positive breast cancer. Identifying and controlling impurities ensures the drug's efficacy and safety. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 002 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Pack Sizes: 2 mg. Product ID: B2694-338792. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 022 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 1779124-68-3. Pack Sizes: 100 mg. Product ID: B2694-338796. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 025 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 2174002-16-3. Pack Sizes: 2 mg. Product ID: B2694-338798. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 026 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Pack Sizes: 2 mg. Product ID: B2694-037182. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 027 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Pack Sizes: 2 mg. Product ID: B2694-338802. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 028 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Pack Sizes: 2 mg. Product ID: B2694-338803. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 029 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 1566082-34-5. Pack Sizes: 2 mg. Product ID: B2694-338800. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 030 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 1211541-02-4. Pack Sizes: 2 mg. Product ID: B2694-338799. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 10 | Palbociclib Impurity 10 is an impurity of Palbociclib, which is a selective cyclin-dependent kinases CDK4 and CDK6 inhibitor used for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 2206135-30-8. Pack Sizes: 2 mg. Product ID: B2694-338793. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 2 | Palbociclib Impurity 2 is an impurity of Palbociclib, which is a selective cyclin-dependent kinases CDK4 and CDK6 inhibitor used for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 2204863-06-7. Pack Sizes: 5 mg. Product ID: B2694-338794. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 4 | An impurity of Palbociclib which is a selective cyclin-dependent kinase (CDK) 4/6 inhibitor to treat ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 1376615-91-6. Pack Sizes: 10 mg. Product ID: B2694-478516. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity F | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 1023594-49-1. Pack Sizes: 100 mg. Product ID: B2694-338797. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Isethionate | Palbociclib is a potent Cdk4/6 inhibitor. Group: Pharmaceutical. CAS No. 827022-33-3. Pack Sizes: 250 mg. Product ID: B0084-463335. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Pyridine N-Oxide | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 2098673-40-4. Pack Sizes: 10 mg. Product ID: B2694-376322. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 6-Desacetyl-6-Bromo Palbociclib | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 851067-56-6. Pack Sizes: 100 mg. Product ID: B1476-283285. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 6-Desacetyl-6-Bromo Palbociclib Hydrochloride | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 850918-83-1. Pack Sizes: 100 mg. Product ID: B1476-284929. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 6-Desacetyl Palbociclib | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 571190-22-2. Pack Sizes: 100 mg. Product ID: B1476-478511. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 6-Desacetyl Palbociclib Hydrochloride | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 571189-66-7. Pack Sizes: 100 mg. Product ID: B1476-284928. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 1,4-Bis(4-nitrophenyl)piperazine | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 16264-05-4. Pack Sizes: 100 mg. Product ID: B1476-166965. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 5-bromo-4-chloro-N-cyclopentylpyrimidin-2-amine | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 1823404-28-9. Pack Sizes: 100 mg. Product ID: B1476-284923. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 6-Bromo-8-cyclopentyl-2-[[5-(4-Boc-1-piperazinyl)-2-pyridyl]amino]-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 571188-82-4. Pack Sizes: 100 mg. Product ID: B1476-282703. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pabociclib Impurity B | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 1651214-74-2. Pack Sizes: 100 mg. Product ID: B1476-478509. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pabociclib Impurity B Hydrochloride | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 1883672-48-7. Pack Sizes: 100 mg. Product ID: B1476-284924. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tert-butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 866084-31-3. Pack Sizes: 100 mg. Product ID: B1476-283415. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| tert-butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-6-vinyl-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 1941177-45-2. Pack Sizes: 2 mg. Product ID: B2694-338795. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| tert-butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 571189-65-6. Pack Sizes: 100 mg. Product ID: B1476-284927. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tri-O-tolylphosphine oxide | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 6163-63-9. Pack Sizes: 100 mg. Product ID: B1476-318503. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
